87 FR 20 pg. 4941 - Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC

Type: NOTICEVolume: 87Number: 20Page: 4941
Docket number: [Docket No. DEA-947]
FR document: [FR Doc. 2022-01816 Filed 1-28-22; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version:  PDF Version
Page: 4941

[top] page 4941

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-947]

Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC

AGENCY:

Drug Enforcement Administration, Justice.

ACTION:

Notice of application.

SUMMARY:

Siegfried USA, LLC. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

DATES:

Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 1, 2022 Such persons may also file a written request for a hearing on the application on or before April 1, 2022.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.33(a), this is notice that on December 8, 2021, Siegfried USA, LLC., 33 Industrial Park Road, Pennsville, New Jersey 08070-3244, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):

Controlled substance Drug code Schedule
Gamma Hydroxybutyric Acid 2010 I
Dihydromorphine 9145 I
Hydromorphinol 9301 I
Amphetamine 1100 II
Lisdexamfetamine 1205 II
Methylphenidate 1724 II
Amobarbital 2125 II
Pentobarbital 2270 II
Secobarbital 2315 II
Phenylacetone 8501 II
Codeine 9050 II
Oxycodone 9143 II
Hydromorphone 9150 II
Hydrocodone 9193 II
Methadone 9250 II
Methadone intermediate 9254 II
Morphine 9300 II
Oripavine 9330 II
Thebaine 9333 II
Opium tincture 9630 II
Oxymorphone 9652 II
Tapentadol 9780 II

The company plans to manufacture the above-listed controlled substance in bulk for development of a new active pharmaceutical ingredient (API) and validation for a Drug Master File submission to the Food and Drug Administration. No other activity for this drug code is authorized for this registration.

Brian S. Besser,

Acting Assistant Administrator.

[FR Doc. 2022-01816 Filed 1-28-22; 8:45 am]

BILLING CODE P